Your browser doesn't support javascript.
loading
Multifunctional Calcium-Manganese Nanomodulator Provides Antitumor Treatment and Improved Immunotherapy via Reprogramming of the Tumor Microenvironment.
Luo, Guanghong; Li, Xing; Lin, Jihui; Ge, Gao; Fang, Jiangli; Song, Wangze; Xiao, Gary Guishan; Zhang, Bo; Peng, Xiaojun; Duo, Yanhong; Tang, Ben Zhong.
Afiliação
  • Luo G; School of Medicine, The 2nd Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Guangdong 518172, P.R. China.
  • Li X; Department of Radiation Oncology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong China.
  • Lin J; School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
  • Ge G; School of Medicine, The 2nd Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Guangdong 518172, P.R. China.
  • Fang J; School of Nursing, Southwest Medical University, Luzhou, Sichuan 646000, China.
  • Song W; Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
  • Xiao GG; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, 171 77, Sweden.
  • Zhang B; State Key Laboratory of Fine Chemicals, Department of Pharmacology, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
  • Peng X; Research Center for Cancer Metabolism, College of Pharmacology, Shenzhen University of Technology, Chinese Academy of Sciences, Shenzhen, 518118, China.
  • Duo Y; State Key Laboratory of Fine Chemicals, Department of Pharmacology, School of Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
  • Tang BZ; School of Medicine, The 2nd Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Guangdong 518172, P.R. China.
ACS Nano ; 17(16): 15449-15465, 2023 08 22.
Article em En | MEDLINE | ID: mdl-37530575
Ions play a vital role in regulating various biological processes, including metabolic and immune homeostasis, which involves tumorigenesis and therapy. Thus, the perturbation of ion homeostasis can induce tumor cell death and evoke immune responses, providing specific antitumor effects. However, antitumor strategies that exploit the effects of multiion perturbation are rare. We herein prepared a pH-responsive nanomodulator by coloading curcumin (CU, a Ca2+ enhancer) with CaCO3 and MnO2 into nanoparticles coated with a cancer cell membrane. This nanoplatform was aimed at reprogramming the tumor microenvironment (TME) and providing an antitumor treatment through ion fluctuation. The obtained nanoplatform, called CM NPs, could neutralize protons by decomposing CaCO3 and attenuating cellular acidity, they could generate Ca2+ and release CU, elevating Ca2+ levels and promoting ROS generation in the mitochondria and endoplasmic reticulum, thus, inducing immunogenic cell death. Mn2+ could decompose the endogenous H2O2 into O2 to relieve hypoxia and enhance the sensitivity of cGAS, activating the cGAS-STING signaling pathway. In addition, this strategy allowed the reprogramming of the immune TME, inducing macrophage polarization and dendritic cell maturation via antigen cross-presentation, thereby increasing the immune system's ability to combat the tumor effectively. Moreover, the as-prepared nanoparticles enhanced the antitumor responses of the αPD1 treatment. This study proposes an effective strategy to combat tumors via the reprogramming of the tumor TME and the alteration of essential ions concentrations. Thus, it shows great potential for future clinical applications as a complementary approach along with other multimodal treatment strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2023 Tipo de documento: Article